CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 62 filers reported holding CELL THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 13,989,346 | $22,676,000 | 0.93% |
| First Heartland Consultants, Inc. | 74,624 | $124,000 | 0.08% |
| Geduld E E | 50,000 | $81,000 | 0.05% |
| WASHINGTON TRUST Co | 346,616 | $562,000 | 0.04% |
| Rotella Capital Management, Inc. | 10,900 | $18,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 201,575 | $327,000 | 0.01% |
| Jane Street Holding, LLC | 488,727 | $792,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,978 | $436,000 | 0.01% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 10,900 | $18,000 | 0.01% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 132,236 | $214,000 | 0.01% |